BioSpace News Archive

31 new and encore presentations, including three late-breakers and three oral presentations, spotlight robust Nurtec ODT, zavegepant and migraine HEOR data.

Immunocore Holdings plc today announces the appointment of Siddharth (Sid) Kaul as a non-Executive member of its Board of Directors, effective June 8, 2022.

BIONIK Laboratories Corp. (OTCPink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home, today reported financial results for the fourth quarter and fiscal year 2022, ended March 31, 2022.

Clinscience extends Calyx’s reliable, expedited imaging services to its global pharmaceutical customers.

Teva to Present Latest Data on AJOVY ® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting.

Eyenovia, Inc., an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print investigational products, announced that its Annual Meeting of Stockholders will be held virtually via live webcast on Thursday, June 16, 2022 at 10:00 am EDT.

Impel Pharmaceuticals (NASDAQ: IMPL), today announced that it will present one oral presentation and three poster presentations from the pivotal, 52-week long, open-label, Phase 3 STOP 301 trial exploring the safety and exploratory efficacy of Trudhesa® (dihydroergotamine mesylate [DHE]) nasal spray (0.725 mg per spray), at the 64TH Annual American Headache Society (AHS) Scientific Meeting.

Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a late-stage clinical biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced multiple presentations at the American Society for Microbiology (ASM) annual Microbe conference, taking place June 9-13, 2022, in Washington, DC.

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced new data from the OPTIC study treating wet age-related macular degeneration (wet AMD) during the Macula Society Annual Meeting in Berlin, Germany.

IceCure Medical Ltd. today announced that KTRFIOS IMPORTACAO E EXPORTACAO LTDA., IceCure’s distributor in Brazil (“KTRFIOS”), has submitted a regulatory filing to the Brazilian Health Regulatory Agency (“ANVISA”) for the approval of ProSense for several indications.